title: A cell-based backup to speed up pandemic influenza vaccine production.
abstract: Influenza vaccines are currently produced through egg-based methods, with one drawback being that this system is slow to respond to the surging global demand during an influenza pandemic. Alternative influenza vaccine production strategies, such as using a cell-based strategy, should be considered in pandemic situations.
authors.affiliation: National Institute of Infectious Diseases and Vaccinology, National Health Research Institutes, 35 Keyan Road, Zhunan, Miaoli 350, Taiwan. minshi@nhri.org.tw
authors.forename: Min-Shi
authors.initials: MS
authors.lastname: Lee
authors.forename: Alan Yung-Chih
authors.initials: AY
authors.lastname: Hu
mesh_terms: D000818:Animals; D018929:Cell Culture Techniques; D002460:Cell Line; D002642:Chick Embryo; D002522:Chlorocebus aethiops; D003584:Cytological Techniques; D004285:Dogs; D006801:Humans; D009980:Influenza A virus / Q000235:genetics / Q000276:immunology / Q000502:physiology*; D007252:Influenza Vaccines / Q000096:biosynthesis* / Q000235:genetics / Q000276:immunology; D007251:Influenza, Human / Q000453:epidemiology / Q000517:prevention & control* / Q000821:virology; D058873:Pandemics; D014709:Vero Cells
chemical_list: D007252:Influenza Vaccines